Waddell & Reed Financial’s AtriCure ATRC Stock Holding History

Waddell & Reed Financial’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-362,777	Closed	-$10.8M	–	453
2019 Q2	$10.8M	Buy	+362,777	New	+$10.6M	0.03%	402
2016 Q4	–	Sell	-301,400	Closed	-$4.77M	–	577
2016 Q3	$4.77M	Buy	301,400 +33,600	+13%	+$517K	0.01%	523
2016 Q2	$3.78M	Hold	267,800	–	–	0.01%	520
2016 Q1	$4.51M	Sell	267,800 -136,200	-34%	-$2.4M	0.01%	497
2015 Q4	$9.07M	Sell	404,000 -41,800	-9%	-$861K	0.01%	423
2015 Q3	$9.77M	Buy	445,800 +17,800	+4%	+$445K	0.02%	408
2015 Q2	$10.5M	Buy	428,000 +172,200	+67%	+$3.85M	0.02%	422
2015 Q1	$5.24M	Buy	255,800 +86,100	+51%	+$1.67M	0.01%	496
2014 Q4	$3.39M	Buy	+169,700	New	+$2.91M	﹤0.01%	513

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Waddell & Reed Financial's ATRC Position: Q3 2019 in Review

Waddell & Reed Financial sold out of AtriCure (ATRC) in Q3 2019, closing a stake of 362,777 shares — an estimated $10.8M sold.

Waddell & Reed Financial first reported a position in ATRC in Q4 2014 and held it in 9 quarters. The position peaked at $10.8M in Q2 2019. 141 funds tracked by Wall St. Rank hold ATRC as of Q3 2019.

Waddell & Reed Financial reported no remaining AtriCure position as of Q3 2019 after selling out during the quarter.
Waddell & Reed Financial sold 362,777 AtriCure shares in Q3 2019, an estimated $10.8M.
Waddell & Reed Financial first reported a position in AtriCure in Q4 2014 and held it in 9 quarters.
Waddell & Reed Financial's AtriCure position peaked at $10.8M in Q2 2019.
141 funds tracked by Wall St. Rank held AtriCure as of Q3 2019.

Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.